NEURALGENE
Neuralgene is a biotechnology company with the focus of developing gene therapy for Neural disorders. Neuralgene’s main development is PRCN-829, an AAV based gene therapy for the treatment of ALS. This gene therapy targets several key underlying mechanisms of ALS. This therapy is designed to target gene delivery to the brain and spinal cord. Neuralgene will be working in conjunction with Helica Labs in Playa Del Carmen, Mexico for the production of it’s gene therapy. PRCN-829 was developed ... from concepts learned with stem cell treatment of ALS. It was determined that stem cells produce substances that inhibit the process of ALS. The problem with stem cell therapy used alone, though it can be beneficial, it does not seem to have permanent lasting results. This has been shown with several different stem cell treatments in regards to ALS. PRCN-829 was developed to provide the benefits that occur with stem cell therapy, but to amplify and lengthen the effects. The effect of AAV gene therapy last for many years and may actually be lifelong.
NEURALGENE
Industry:
Biotechnology Medical
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.neuralgene.com
Status:
Active
Contact:
(251) 943-9409
Email Addresses:
[email protected]
Technology used in webpage:
Yahoo DNS Yahoo! Business Email Cybercon
Similar Organizations
3D Custom Collagen
3D Custom Collagen is a biotechnology company.
Current Employees Featured
Official Site Inspections
http://www.neuralgene.com
- Host name: cpanel302.turbify.biz
- IP address: 34.224.217.31
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Neuralgene"
Neuralgene - Crunchbase Company Profile & Funding
Neuralgene is a biotechnology company with the focus of developing gene therapy for Neural disorders. Neuralgene’s main development is PRCN-829, an AAV based gene therapy for the …See details»
Neuralgene - Contacts, Employees, Board Members, Advisors
Neuralgene has 1 current employee profile, CEO and Director of R&D Jason R. Williams.See details»
Neurogene | Developing life-changing Genetic Medicines
Our focus is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases. We are building a gene therapy pipeline to help address the high unmet need for rare neurological …See details»
Neuralgene - VentureRadar
Neuralgene is a biotech company focused on AAV gene therapy, which produces multiple proteins for the treatment of neurodegenerative disorders such as ALS and Parkinson’s. …See details»
Neurogene Inc. - LinkedIn
At Neurogene, we are working to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families. We are building a team of …See details»
Neuralgene - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Neuralgene is actively using 5 technologies for its website, according to BuiltWith. These include Amazon, PHP, and Amazon Virginia Region. Neuralgene is a biotechnology company.See details»
Research programme: AAV-based gene therapies - Neuralgene
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.See details»
Release: Gene Therapy Developed for ALS Treatment: New
Apr 12, 2013 · Neuralgene's neurotropic AAV-based gene therapy platform for the treatment of neurodegenerative diseases is based on the stem cell work performed by Jason Williams, …See details»
Biotechnology Company Neuralgene Provides Hope to Children …
GULF SHORES, Ala., April 29, 2014 /PRNewswire/ -- If successful, Neuralgene's (http://www.neuralgene.com) PRCN-323 treatment could significantly change the prognosis for …See details»
Neuralgene to start animal studies to evaluate efficacy of PRCN …
Neuralgene, a startup biotech company, will begin animal studies in May to evaluate the efficacy of PRCN-829, its new gene therapy agent for the treatment of amyotrophic lateral sclerosis …See details»
Gene Therapy Developed for ALS Treatment: New …
Apr 12, 2013 · Neuralgene is a startup biotech company focused on AAV gene therapy, which produces multiple proteins for the treatment of neurodegenerative disorders such as ALS and Parkinson's. PRCN-829 is a...See details»
Biotech Firm Neuralgene Begins Human Testing For New ALD …
May 1, 2014 · Neuralgene announced the enrollment of the first human patient in its new genetic therapy PRCN-323 testing for rare disease adrenoleukodystrophy (ALD). …See details»
Large-scale neurophysiology and single-cell profiling in human ...
Jun 19, 2024 · Advances in large-scale single-unit human neurophysiology, single-cell RNA sequencing, spatial transcriptomics and long-term ex vivo tissue culture of surgically resected …See details»
Genetics of human brain development | Nature Reviews Genetics
Jul 28, 2023 · Here, we review our current knowledge of complex genetic regulation of each key step of human brain development through the lens of evolutionary specialization and …See details»
How the epigenome integrates information and reshapes the …
Jan 29, 2019 · We explore how epigenetic mechanisms give rise to stable alterations in neuronal function by modifying synaptic structure and function, and highlight studies that demonstrate …See details»
Joint epigenome profiling reveals cell-type-specific gene …
Nov 23, 2023 · Here, we describe a method—3D genome, RNA, accessibility and methylation sequencing (3DRAM-seq)—that simultaneously interrogates spatial genome organization, …See details»
Epigenetic mechanisms in neurogenesis - Nature Reviews …
Jun 23, 2016 · Here, we review recent advances in our understanding of epigenetic regulation in neurogenesis and its dysregulation in brain disorders, including discussion of newly identified …See details»
Neurogenesis, neuronal migration, and axon guidance
Jan 1, 2020 · We discuss mechanisms related to neural stem cells proliferation, migration, terminal translocation of neuronal progenitors, and axon guidance and pathfinding.See details»
Mapping gene transcription and neurocognition across human
Mar 25, 2021 · Regulation of gene expression drives protein interactions that govern synaptic wiring and neuronal activity. The resulting coordinated activity among neuronal populations …See details»
Extended intergenic DNA contributes to neuron-specific ... - Nature
May 18, 2022 · Extended intergenic regions contain twice as many active enhancers in neural tissues compared to other tissues. Neural genes with extended intergenic regions are globally …See details»